Back

Effect of preoperative low-molecular-weight heparin on major adverse cardiac events after coronary artery bypass grafting

27 August 2018 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 4 - Impact of optimizing perioperative management on long term outcomes after coronary artery bypass grafting surgery Coronary Arteries ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Dachuan Gu

Fuwai Hospital, CAMS and PUMC, Beijing (China)

8 More presentations in this session

Presentation thumbnail
Doctor L. Seoane (Buenos Aires, AR)
Abstract Slides
Presentation thumbnail
Doctor S. Mikheev (Moscow, RU)
Abstract
Presentation thumbnail
Doctor M. Cybularz-Bednarek (Dresden, DE)
Abstract
Presentation thumbnail
Doctor A. Kaushik (Jodhpur, IN)
Abstract Slides
Presentation thumbnail
Doctor R. Casalino (Sao Paulo, BR)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 4 - Impact of optimizing perioperative management on long term outcomes after coronary artery bypass grafting surgery

The Event

Event poster

ESC Congress 2018

27 August 2018 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Direct oral anticoagulants versus low-molecular-weight heparin for thromboprophylaxis in cancer-related surgeries: a meta-analysis of efficacy and safety outcomes
31 August 2025
thumbnail
Congress Presentation
Levosimendan in preoperative medical preparation in coronary artery bypass grafting (CABG) candidates with low left ventricular ejection fraction (LVEF): to whom and when?
29 June 2021
thumbnail
Congress Presentation
Post-discharge major bleeding, myocardial infarction and mortality risk after coronary artery bypass grafting: A nationwide cohort study from the SWEDEHEART registry
27 August 2021
thumbnail
Congress Session
State-of-the-art antithrombotic treatment in acute coronary syndromes: a paradigm shift?
14 March 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources